ClinicalTrials.Veeva

Menu

The Incidence of Hypocalcemia in Pregnant Women at Siriraj Hospital (HypoCal)

S

Siriraj Hospital

Status

Active, not recruiting

Conditions

Hypocalcemia in Pregnancy

Treatments

Drug: Calcium supplement

Study type

Interventional

Funder types

Other

Identifiers

NCT06160479
Si 1003/2021

Details and patient eligibility

About

Calcium is an essential element for fundamental physiological functions and during pregnancy. However, higher calcium intake can induce constipation, flatulence, nausea, or kidney stones. This study aims to evaluate the incidence of hypocalcemia among pregnant women in the first half of pregnancy in Thailand. Also, Comparison of calcium level in pregnant women in the third trimester who received and not received calcium during pregnancy.

Full description

The primary outcome is the incidence of hypocalcemia among pregnant women in the first half of pregnancy. This study also has secondary objectives. The one is associating factors with calcium level. After getting the results of maternal calcium level, the normal calcium level group will be divided into 2 groups for receiving calcium 1 g/day and no receiving calcium supplement. Another with hypocalcemia group will be decided into 2 groups for receiving calcium 1 g/day and 2 g/day. The calcium level was collected again in the third trimester.

Enrollment

444 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pregnant women who attend antenatal care clinic in Siriraj Hospital
  • Pregnant women with gestation less than 20 weeks of gestation
  • Singleton pregnancy

Exclusion criteria

  • Pregnant women who has underlying diseases including liver disease and vitamin D deficiency
  • Pregnant women are malnutrition patients
  • Pregnant women who receive calcium supplement before enrollment

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

444 participants in 4 patient groups

Normal calcium level with no receiving calcium supplement
No Intervention group
Description:
Pregnant women with normal calcium level in the first half of pregnancy do not receive calcium supplement.
Normal calcium level with receiving calcium supplement 1g/day
Experimental group
Description:
Pregnant women with normal calcium level in the first half of pregnancy receive calcium supplement 1g/day.
Treatment:
Drug: Calcium supplement
Hypocalcemia with receiving calcium supplement 1g/day
Experimental group
Description:
Pregnant women with hypocalcemia in the first half of pregnancy receive calcium supplement 1g/day.
Treatment:
Drug: Calcium supplement
Hypocalcemia level with receiving calcium supplement 2g/day
Experimental group
Description:
Pregnant women with hypocalcemia in the first half of pregnancy receive calcium supplement 2g/day.
Treatment:
Drug: Calcium supplement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems